Life ScienceCompany
Parexel M&A Summary
Parexel has acquired 16 companies of its own. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
Parexel’s largest acquisition to date was in 2012, when it acquired Liquent for $72M. Parexel has acquired in 5 different US states, and 5 countries. The Company’s most targeted sectors include life science (57%) and business services (13%).
Parexel Ownership
Who owns Parexel?
Parexel is owned by EQT and Goldman Sachs Merchant Banking. It was acquired on July 2, 2021.
Is Parexel PE-backed?
Yes. Parexel is owned by private equity investors EQT and Goldman Sachs Merchant Banking.
Was Parexel formerly PE-backed?
Yes. Parexel was formerly owned by 2 private investors.
Parexel Business Overview
Where is Parexel headquartered?
Parexel is headquartered in Durham, North Carolina.
What is Parexel’s revenue?
Parexel disclosed revenue of 2,330M USD for 2015 and 2,266M USD for 2014.
What sector is Parexel in?
Parexel is a life science company.
When was Parexel founded?
Parexel was founded in 1983.
M&A Summary
-
M&A Total Activity17
- M&A Buy Activity16
- M&A Sell Activity1
- Total Sectors Invested 6
- Total Countries Invested 5
- M&A Buy/Sell Connections 3
- M&A Advisors 1
Unlimited Searches
